Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MCGUIRE WP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Im, DD; McGuire, WP; Rosenshein, NB
      Contemporary management of ovarian cancer

      OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    2. McGuire, WP
      Intraperitoneal therapy for ovarian cancer: A sacrifice bunt

      JOURNAL OF CLINICAL ONCOLOGY
    3. Fleming, GF; Fowler, JM; Waggoner, SE; Copeland, LJ; Greer, BE; Horowitz, I; Sutton, G; Schilder, RJ; Fracasso, PM; Ball, HG; McGuire, WP
      Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: A Gynecologic Oncology Group Study

      JOURNAL OF CLINICAL ONCOLOGY
    4. Fracasso, PM; Brady, MF; Moore, DH; Walker, JL; Rose, PG; Letvak, L; Grogan, TM; McGuire, WP
      Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovariancarcinoma: A gynecologic oncology group study

      JOURNAL OF CLINICAL ONCOLOGY
    5. Giblin, J; Fanucchi, MP; McGuire, WP
      Clear cell carcinoma of the ovary - A remarkable case

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    6. McGuire, WP
      The story of taxol - Nature and politics in the pursuit of an anti-cancer drug

      SCIENCE
    7. McGuire, WP; Blessing, JA; Bookman, MA; Lentz, SS; Dunton, CJ
      Topotecan has substantial antitumor activity as first-line salvage therapyin platinum-sensitive epithelial ovarian carcinoma: A Gynecologic OncologyGroup study

      JOURNAL OF CLINICAL ONCOLOGY
    8. Rose, PG; Rodriguez, M; Waggoner, S; Greer, BE; Horowitz, IR; Fowler, JM; McGuire, WP
      Phase I study of paclitaxel, carboplatin, and increasing days of prolongedoral etoposide in ovarian, peritoneal, and tubal carcinoma: A Gynecologic Oncology Group study

      JOURNAL OF CLINICAL ONCOLOGY
    9. Fleming, GF; Roth, BJ; Baker, SD; Sutton, GP; Look, KY; Muggia, FM; Fracasso, PM; McGuire, WP
      Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma - A gynecologic oncology group study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    10. McGuire, WP
      High-dose chemotherapeutic approaches to ovarian cancer management

      SEMINARS IN ONCOLOGY
    11. McGuire, WP
      Confirmation of the "old" standard of care for ovarian cancer and a challenge

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    12. McGuire, WP; Brady, MF; Ozols, RF
      The Gynecologic Oncology Group experience in ovarian cancer

      ANNALS OF ONCOLOGY
    13. Berek, JS; Bertelsen, K; du Bois, A; Brady, MF; Carmichael, J; Eisenhauer, EA; Gore, M; Grenman, S; Hamilton, TC; Hansen, SW; Harper, PG; Horvath, G; Kaye, SB; Luck, HJ; Lund, B; McGuire, WP; Neijt, JP; Ozols, RF; Parmar, MKB; Piccart-Gebhart, MJ; van Rijswijk, R; Rosenberg, P; Rustin, GJS; Sessa, C; Thigpen, JT; Trope, C; Tuxen, MK; Vergote, I; Vermorken, JB; Willemse, PHB
      Advanced epithelial ovarian cancer: 1998 consensus statements

      ANNALS OF ONCOLOGY
    14. Bridgewater, JA; Nelstrop, AE; Rustin, GJS; Gore, ME; McGuire, WP; Hoskins, WJ
      Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel

      JOURNAL OF CLINICAL ONCOLOGY
    15. Piccart, MJ; McGuire, WP
      ICON2 trial

      LANCET
    16. Robinson, JB; Im, DD; Logan, L; McGuire, WP; Rosenshein, NB
      Extraovarian granulosa cell tumor

      GYNECOLOGIC ONCOLOGY
    17. Marrano, NN; Blevins, LS; Gal, AA; McGuire, WP
      Pancreatic polypeptide hypersecretion associated with a neuroendocrine carcinoma of the gallbladder

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    18. MARKMAN M; ROSE PG; JONES E; HOROWITZ IR; KENNEDY A; WEBSTER K; BELINSON J; FUSCO N; FLUELLEN L; KULP B; PETERSON G; MCGUIRE WP
      96-HOUR INFUSIONAL PACLITAXEL AS SALVAGE THERAPY OF OVARIAN-CANCER PATIENTS PREVIOUSLY FAILING TREATMENT WITH 3-HOUR OR 24-HOUR PACLITAXEL INFUSION REGIMENS

      Journal of clinical oncology
    19. ASBURY R; BLESSING JA; REID GC; MCGUIRE WP
      A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH ENDOMETRIAL CANCER - AGYNECOLOGIC-ONCOLOGY-GROUP STUDY

      American journal of clinical oncology
    20. MCGUIRE WP
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW OR STEM-CELL RECONSTITUTION FOR SOLID TUMORS

      Current problems in cancer
    21. MCGUIRE WP; OZOLS RF
      CHEMOTHERAPY OF ADVANCED OVARIAN-CANCER

      Seminars in oncology
    22. McGuire, WP; Ozols, RF
      Chemotherapy of advanced ovarian cancer (vol 25, pg 340, 1998)

      SEMINARS IN ONCOLOGY
    23. KEANE TE; ELGALLEY RES; SUN C; PETROS JA; DILLAHEY D; GOMAA A; GRAHAM SD; MCGUIRE WP
      CAMPTOTHECIN ANALOGUES CISPLATIN - AN EFFECTIVE TREATMENT OF ADVANCEDBLADDER-CANCER IN A PRECLINICAL IN-VIVO MODEL SYSTEM/

      The Journal of urology
    24. HOSKINS WJ; MCGUIRE WP; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      COMBINATION PACLITAXEL (TAXOL(R))-CISPLATIN VS CYCLOPHOSPHAMIDE-CISPLATIN AS PRIMARY THERAPY IN PATIENTS WITH SUBOPTIMALLY DEBULKED ADVANCED OVARIAN-CANCER

      International journal of gynecological cancer
    25. MCGUIRE WP
      HOW MANY MORE NAILS TO SEAL THE COFFIN OF DOSE INTENSITY

      Annals of oncology
    26. OREILLY S; FLEMING GF; BAKER SD; WALCZAK JR; BOOKMAN MA; MCGUIRE WP; SCHILDER RJ; ALVAREZ RD; ARMSTRONG DK; HOROWITZ IR; OZOLS RF; ROWINSKY EK
      PHASE-I TRIAL AND PHARMACOLOGICAL TRIAL OF SEQUENCES OF PACLITAXEL AND TOPOTECAN IN PREVIOUSLY TREATED OVARIAN EPITHELIAL MALIGNANCIES - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    27. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKPEARSON DL; DAVIDSON M
      COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-IIIAND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Seminars in oncology
    28. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL TAXOL(R) AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-III AND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      International journal of gynecological cancer
    29. RUSTIN GJS; NELSTROP AE; MCCLEAN P; BRADY MF; MCGUIRE WP; HOSKINS WJ; MITCHELL H; LAMBERT HE
      DEFINING RESPONSE OF OVARIAN-CARCINOMA TO INITIAL CHEMOTHERAPY ACCORDING TO SERUM CA-125

      Journal of clinical oncology
    30. MCGUIRE WP; BLESSING JA; MOORE D; LENTZ SS; PHOTOPULOS G
      PACLITAXEL HAS MODERATE ACTIVITY IN SQUAMOUS CERVIX CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    31. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      CYCLOPHOSPHAMIDE AND CISPLATIN VERSUS PACLITAXEL AND CISPLATIN - A PHASE-III RANDOMIZED TRIAL IN PATIENTS WITH SUBOPTIMAL STAGE III IV OVARIAN-CANCER (FROM THE GYNECOLOGIC-ONCOLOGY-GROUP)/

      Seminars in oncology
    32. MCGUIRE WP; HOSKINS WJ; BRADY MF
      CHEMOTHERAPY FOR OVARIAN-CANCER - REPLY

      The New England journal of medicine
    33. MCGUIRE WP
      CYCLOPHOSPHAMIDE AND CISPLATIN COMPARED WITH PACLITAXEL AND CISPLATININ PATIENTS WITH STAGE-III AND STAGE-IV OVARIAN-CANCER (VOL 334, PG 1, 1996)

      The New England journal of medicine
    34. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      CYCLOPHOSPHAMIDE AND CISPLATIN COMPARED WITH PACLITAXEL AND CISPLATININ PATIENTS WITH STAGE-III AND STAGE-IV OVARIAN-CANCER

      The New England journal of medicine
    35. MCGUIRE WP; HOSKINS WJ; BRADY MF; HOMESLEY HD; CREASMAN WT; BERMAN ML; BALL H; BEREK JS; WOODWARD J
      ASSESSMENT OF DOSE-INTENSIVE THERAPY IN SUBOPTIMALLY DEBULKED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    36. WHOLEY MH; MEYERROSE GE; MCGUIRE WP; REINHARDT MJ; SOSTRE S
      ENDOBRONCHIAL LESION FROM METASTATIC OVARIAN-CARCINOMA RESULTING IN PARTIAL RIGHT MAINSTEM OBSTRUCTION DEMONSTRATED BY LUNG SCINTIGRAPHY

      Clinical nuclear medicine
    37. SLICHENMYER WJ; DONEHOWER RC; CHEN TL; BOWLING MK; MCGUIRE WP; ROWINSKY EK
      PRETREATMENT H-2-RECEPTOR ANTAGONISTS THAT DIFFER IN P450 MODULATION ACTIVITY - COMPARATIVE EFFECTS ON PACLITAXEL CLEARANCE RATES AND NEUTROPENIA

      Cancer chemotherapy and pharmacology
    38. THIGPEN T; VANCE RB; MCGUIRE WP; HOSKINS WJ; BRADY M
      ROLE OF PACLITAXEL IN THE MANAGEMENT OF CELOMIC EPITHELIAL CARCINOMA OF THE OVARY - A REVIEW WITH EMPHASIS ON THE GYNECOLOGIC-ONCOLOGY-GROUP EXPERIENCE

      Seminars in oncology
    39. HOROWITZ IR; COPAS PR; AARONOFF M; SPANN CO; MCGUIRE WP
      ENDOMETRIAL ADENOCARCINOMA FOLLOWING ENDOMETRIAL ABLATION FOR POSTMENOPAUSAL BLEEDING

      Gynecologic oncology
    40. MCGUIRE WP
      UNTITLED - REPLY

      Gynecologic oncology
    41. QAZI F; MCGUIRE WP
      THE TREATMENT OF EPITHELIAL OVARIAN-CANCER

      Ca
    42. HOLMES CE; RUCKDESCHEL JC; JOHNSTON M; THOMAS PA; DESLAURIERS J; GROVER FL; HILL LD; FELD R; GINSBERG RJ; MOUNTAIN CF; DZUIBAN S; KIELY M; MCKNEALLY MF; MOORES DWO; RAMNES C; WAGNER H; BUNN P; CHU H; DIENHART D; HAZUKA M; KINZIE J; SORENSEN J; VANCE V; BRAUN T; HOPEMAN A; KANE M; RUSS P; WHITMAN GJR; FALL SM; HANSEN DP; HENDERSON RH; MONCRIEF CL; PAULING F; SIMS J; TELL D; WISELYCARR S; ABERNATHY CM; CLARK DA; MCCROSKEY B; MOORE G; MOORE F; MYERS A; WHITE M; BROOKS RJ; BULL M; JOHNSON FB; NEIMYR M; PAQUETTE FR; SACCOMANNO G; LAD T; HERMANSEN K; LIEBNER E; MCGUIRE WP; FRY W; STEMPELFELD B; ALEXANDER JC; BECK J; GARCES RM; IMPERATO JP; KAHANDEKAR J; KNOP R; LOCKER G; MERKEL DE; PANELLA JS; ROCHESTER D; VICTOR TA; JOHNSON C; JOOB AW; ROBINSON P; ROSEN S; SHIELDS T; DOOLEY S; TIO FO; HOLLAND C; TREASURE RL; GOTTFRIED B; BEDDINGFIELD G; BOWER J; CHENG D; DALY MB; LADD WA; LEACH C; MURPHY K; QUINTON R; SMITH VC; YOUNG ME; BLANTON M; BRIGGS R; GRISHKIN BA; HELSEL R; JACKSON D; JACKSON ME; YOUNG R; ZALOZNIK A; BLOCK K; DAIL DH; DREIS D; GUYTON SW; HAFERMANN M; HAMMAR SP; JOLLY PC; MORGAN E; SPRINGMEYER S; TAYLOR EW; WEIDEN PW; KNUDSEN N; LIVINGSTON RB; RUSCH VW; GRAFTON C; LERICHE J; MURRAY N; PAGE R; GOODMAN GE; AYE RW; EVANS KG; MILLER RR; NELEMS B; HIGANO C; BERGSAGEL D; BROWN TC; CURTIS J; PAYNE D; PRINGLE JF; QUIRT I; STEWARD L; WARR D; YEOH L; BURKES R; COOTER N; GOLDBERG M; MULLEN B; SCHMOCKER B; HARRIS F; ILVES R; SINCLAIR JM; SPRATT E; BAKER M; CHAMBERLAIN DW; COOPER JD; DESANTIS D; EVANS WK; PATTERSON GA; PEARSON FG; RITCHIE AC; SHEPHERD FA; TAYLOR D; TODD TRJ; WEBSTER J; WINTON TL; KIRBY TJ; LIPA M; FRENCH S; SUTTON D; WARNER E; WATERS PF; JONES D; HOLMES EC; SELCH RA; SHIPLACOFF J; GANZ P; SILVERMAN B; HASKELL C; SADEGHI A; WILLIAMS A; WOLLMAN J; BLOCH JH; CORDER MP; HERMES K; LUKEMAN JM; MURPHY A; PIANTADOSI S; GOODMAN S; RUBINSTEIN LV; GAIL MH; BOSSENGA M; LAKE WH; LONG S
      RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER

      The Annals of thoracic surgery
    43. HURWITZ HI; MCGUIRE WP
      PRIMARY CHEMOTHERAPY IN EPITHELIAL OVARIAN-CANCER

      Obstetrics and gynecology clinics of North America
    44. CALDAS C; MORRIS LE; MCGUIRE WP
      SALVAGE THERAPY IN EPITHELIAL OVARIAN-CANCER

      Obstetrics and gynecology clinics of North America
    45. TRIMBLE EL; ARBUCK SG; MCGUIRE WP
      OPTIONS FOR PRIMARY CHEMOTHERAPY OF EPITHELIAL OVARIAN-CANCER - TAXANES

      Gynecologic oncology
    46. SUTTON GP; BLESSING JA; HOMESLEY HD; MCGUIRE WP; ADCOCK L
      PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN REFRACTORY ADENOCARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Cancer
    47. WU LT; AVERBUCH SD; BALL DW; DEBUSTROS A; BAYLIN SB; MCGUIRE WP
      TREATMENT OF ADVANCED MEDULLARY-THYROID CARCINOMA WITH A COMBINATION OF CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE

      Cancer
    48. HOSKINS WJ; MCGUIRE WP; BRADY MF; HOMESLEY HD; CREASMAN WT; BERMAN M; BALL H; BEREK JS
      THE EFFECT OF DIAMETER OF LARGEST RESIDUAL DISEASE ON SURVIVAL AFTER PRIMARY CYTOREDUCTIVE SURGERY IN PATIENTS WITH SUBOPTIMAL RESIDUAL EPITHELIAL OVARIAN-CARCINOMA

      American journal of obstetrics and gynecology
    49. PEEREBOOM DM; DONEHOWER RC; EISENHAUER EA; MCGUIRE WP; ONETTO N; HUBBARD JL; PICCART M; GIANNI L; ROWINSKY EK
      SUCCESSFUL RETREATMENT WITH TAXOL AFTER MAJOR HYPERSENSITIVITY REACTIONS

      Journal of clinical oncology
    50. CALDAS C; MCGUIRE WP
      PACLITAXEL (TAXOL(R)) THERAPY IN OVARIAN-CARCINOMA

      Seminars in oncology
    51. MCGUIRE WP
      TAXOL - A NEW DRUG WITH SIGNIFICANT ACTIVITY AS A SALVAGE THERAPY IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA

      Gynecologic oncology
    52. SUTTON GP; BLESSING JA; DISAIA PJ; MCGUIRE WP
      PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN NONSQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

      Gynecologic oncology
    53. ROWINSKY EK; GROCHOW LB; HENDRICKS CB; ETTINGER DS; FORASTIERE AA; HUROWITZ LA; MCGUIRE WP; SARTORIUS SE; LUBEJKO BG; KAUFMANN SH; DONEHOWER RC
      PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR

      Journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 02:59:55